EPM speaks to Abdullah Al-Hakimi, senior quality compliance specialist at Autolus and Robert Gaertner, strategy director for Veeva Vault Quality, about working during Covid-19 and why quality processes are so important in pharma.
Questions
To begin could you please introduce yourselves and the companies you work for?
Abdullah: Autolus is at the forefront of a revolution in cancer treatment. We focus on the development of precisely targeted, controlled and highly active T-cell therapies for the treatment of both haematological cancers and solid tumours. We work in partnership with physicians and other healthcare providers, we extract immune cells from patients, equip them with a receptor that targets the cancer cell and infuse them back into the patient in order to develop therapies.
Robert: Veeva Systems is the leader in cloud-based software dedicated to the global life sciences industry. Our Vault Quality Suite unifies quality processes, controlled content, and GxP training on a single digital platform. It enables life sciences companies to modernise quality management and drive compliance and operational innovation.